ENGLISH EDITION
Sleep Technology with a Lighter Routine: A New Approach to Night-Time Rest (Translation)
This article introduces a night patch concept in the context of sleep-related concerns and discusses the value of convenient transdermal product formats.
Read the original Chinese article: 睡眠黑科技，轻负担护节律！晚安贴重新定义休息新方式 →The article introduces a night-patch concept against the background of sleep-related concerns. It quotes the 2024 China Sleep Economy White Paper as reporting more than 300 million people with such concerns, particularly working adults aged 25–45 and middle-aged and older people.
Why investigate a different delivery route?
The source discusses oral melatonin absorption and first-pass metabolism, quoting approximately 15% availability from literature. It identifies variability, timing and dose control as development considerations. The quoted value is not a dosing rule and does not establish superiority of another delivery route.
The night-patch development concept
The concept uses RT-SMP® printing to incorporate melatonin and botanical ingredients in dissolving microcrystal arrays. The source illustrates application at the inner wrist or behind the ear and describes a controlled-release design targeting 6–8 hours. That duration is a reported design claim, not a verified clinical sleep outcome or a general instruction for use.
Ingredients discussed
The original formulation discussion names a “sleep peptide”, GABA (gamma-aminobutyric acid) and sour jujube seed extract alongside melatonin. It positions the combination around bedtime relaxation. Ingredient names alone do not demonstrate transdermal exposure, safety or an effect on insomnia.
The article quotes a 2024 melatonin-related market value of RMB 1.54 billion. This is historical market context, not product revenue. The concept's intended use, evidence and market-specific regulatory status require separate assessment before commercialisation.